1. Home
  2. ANPA vs ELTX Comparison

ANPA vs ELTX Comparison

Compare ANPA & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rich Sparkle Holdings Limited Ordinary Shares

ANPA

Rich Sparkle Holdings Limited Ordinary Shares

N/A

Current Price

$1.16

Market Cap

47.0M

Sector

N/A

ML Signal

N/A

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

N/A

Current Price

$1.52

Market Cap

45.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ANPA
ELTX
Founded
2016
2011
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
47.0M
45.6M
IPO Year
2024
2014

Fundamental Metrics

Financial Performance
Metric
ANPA
ELTX
Price
$1.16
$1.52
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
★ $13.00
AVG Volume (30 Days)
18.1K
★ 305.0K
Earning Date
09-30-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 39.29
EPS
★ N/A
N/A
Revenue
N/A
★ $2,301,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$1.14
$1.25
52 Week High
$180.64
$16.00

Technical Indicators

Market Signals
Indicator
ANPA
ELTX
Relative Strength Index (RSI) 26.46 40.97
Support Level N/A $1.35
Resistance Level $2.18 $1.98
Average True Range (ATR) 0.10 0.19
MACD 0.02 0.01
Stochastic Oscillator 11.34 42.19

Price Performance

Historical Comparison
ANPA
ELTX

About ANPA Rich Sparkle Holdings Limited Ordinary Shares

Rich Sparkle Holdings Ltd is a holding company conducting its operations as a professional specialist in the provision of financial printing services such as printing, typesetting and translation, advisory services including Environmental, Social and Governance (ESG) and internal control reporting services and other services including standalone annual general meeting and extraordinary general meeting supporting service and other standalone services, through its sole operating subsidiary in Hong Kong. Its segments include Financial printing services such as printing, typesetting and translation, Advisory services including Environmental, Social and Governance Report and Other services.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.

Share on Social Networks: